Literature DB >> 12038967

Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria).

Smaragdi Antonopoulou1, Alexandra Oikonomou, Haralabos C Karantonis, Elizabeth Fragopoulou, Adriani Pantazidou.   

Abstract

The role of platelet-activating factor (PAF) as a mediator appeared in rather primitive organisms like protozoans and was maintained in more evolved organisms. No reports exist for the presence of PAF or PAF analogues - or even compounds that exhibit PAF-like activity - in cyanobacteria, even though they belong to a a group of organisms at a low evolutionary level where the content of alkylacyl forms of ether lipids is expected to be high. In addition, cyanobacteria serve as a rich source of novel bioactive metabolites. In the present study the total lipids of a strain of Scytonema julianum, a filamentous cyanobacterium isolated from a Greek cave, were separated into neutral lipids and phospholipids, the latter being further fractionated by HPLC. Each phospholipid fraction was tested in vitro for its ability to inhibit PAF-, arachidonic acid- and ADP-induced washed-rabbit-platelet aggregation and/or to cause platelet aggregation. Two types of phospholipids causing platelet aggregation were detected and shown to be an acetylsphingomyelin and an acylacetylglycerol phosphoacetylated glycolipid. The existence of the sphingomyelin analogues is very important, since ceramides, cerebrosides and related lipids are intracellular second messengers. The identification of the phosphoglycoglycerolipid demonstrates a new type of lipid in cyanobacteria, namely one that exhibits a biological activity very similar to that of PAF. Its presence reinforces the concept that PAF is a member of a large family of lipid mediators, apparently having different physiological roles in prokaryotic and eukaryotic organisms. In addition, Scytonema julianum contains a phosphatidylcholine (C(16:0)/(18:2)), even though bacteria in general seldom contain choline-containing phosphoacylglycerols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038967      PMCID: PMC1222851          DOI: 10.1042/BJ20020146

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Structural determination of sphingomyelin by tandem mass spectrometry with electrospray ionization.

Authors:  F F Hsu; J Turk
Journal:  J Am Soc Mass Spectrom       Date:  2000-05       Impact factor: 3.109

2.  Separation of biologically active lipids from red wine.

Authors:  E Fragopoulou; T Nomikos; S Antonopoulou; C A Mitsopoulou; C A Demopoulos
Journal:  J Agric Food Chem       Date:  2000-04       Impact factor: 5.279

3.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 4.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 5.  Ether lipids and platelet-activating factor: evolution and cellular function.

Authors:  V I Kulikov; G I Muzya
Journal:  Biochemistry (Mosc)       Date:  1997-10       Impact factor: 2.487

6.  High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection.

Authors:  N K Andrikopoulos; C A Demopoulos; A Siafaka-Kapadai
Journal:  J Chromatogr       Date:  1986-08-29

Review 7.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

8.  Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry.

Authors:  B Brügger; G Erben; R Sandhoff; F T Wieland; W D Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Paf-acether production by Escherichia coli.

Authors:  Y Denizot; E Dassa; J Benveniste; Y Thomas
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

10.  Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells.

Authors:  R Nakayama; H Kumagai; K Saito
Journal:  Biochim Biophys Acta       Date:  1994-03-02
View more
  6 in total

1.  Partial Purification and Characterization of an Elastase-inhibitory Lipid Derivative from a Cyanobacterium, Microcystis Ku2.

Authors:  Suvendra Nath Bagchi; Shubhro Kamal Ghosh
Journal:  Indian J Microbiol       Date:  2011-01-26       Impact factor: 2.461

2.  Polar lipids and fatty acids of three wild cyanobacterial strains of the genus Chroococcidiopsis.

Authors:  T Rezanka; I Víden; J V Go; I Dor; V M Dembitsky
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Ancient photosynthetic eukaryote biofilms in an Atacama Desert coastal cave.

Authors:  A Azúa-Bustos; C González-Silva; R A Mancilla; L Salas; R E Palma; J J Wynne; C P McKay; R Vicuña
Journal:  Microb Ecol       Date:  2009-03-05       Impact factor: 4.552

4.  Structural Elucidation of Irish Ale Bioactive Polar Lipids with Antithrombotic Properties.

Authors:  Alexandros Tsoupras; Ronan Lordan; Eoin O'Keefe; Katie Shiels; Sushanta Kumar Saha; Ioannis Zabetakis
Journal:  Biomolecules       Date:  2020-07-18

5.  Genetic and lipidomic analyses suggest that Nostoc punctiforme, a plant-symbiotic cyanobacterium, does not produce sphingolipids.

Authors:  Samuel Belton; Nadia Lamari; Lars S Jermiin; Vicente Mariscal; Enrique Flores; Paul F McCabe; Carl K Y Ng
Journal:  Access Microbiol       Date:  2022-01-21

6.  Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.

Authors:  T E Bapiro; K K Frese; A Courtin; J L Bramhall; B Madhu; N Cook; A Neesse; J R Griffiths; D A Tuveson; D I Jodrell; F M Richards
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.